Head and Neck Cancer Proteomic Advances and Biomarker Achievements

被引:54
|
作者
Berto Rezende, Taia Maria [1 ]
Freire, Mirna de Souza [1 ]
Franco, Octavio Luiz [1 ]
机构
[1] Univ Catolica Brasilia, Ctr Prote & Biochem Anal, Brasilia, DF, Brazil
关键词
head and neck cancer; proteomics; cancer risk factors; cancer pathogenesis; diagnostic biomarkers; SQUAMOUS-CELL CARCINOMA; EPIDERMAL-GROWTH-FACTOR; 2-DIMENSIONAL GEL-ELECTROPHORESIS; LASER CAPTURE MICRODISSECTION; ORAL EPITHELIAL DYSPLASIA; IMAGING MASS-SPECTROMETRY; UPPER AERODIGESTIVE TRACT; PROTEIN PROFILE ANALYSIS; NASOPHARYNGEAL CARCINOMA; FACTOR RECEPTOR;
D O I
10.1002/cncr.25245
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumors of the head and neck comprise an important neoplasia group, the incidence of which is increasing in many parts of the world. Recent advances in diagnostic and therapeutic techniques for these lesions have yielded novel molecular targets, uncovered signal pathway dominance, and advanced early cancer detection. Proteomics is a powerful tool for investigating the distribution of proteins and small molecules within biological systems through the analysis of different types of samples. The proteomic profiles of different types of cancer have been studied, and this has provided remarkable advances in cancer understanding. This review covers recent advances for head and neck cancer; it encompasses the risk factors, pathogenesis, proteomic tools that can help in understanding cancer, and new proteomic findings in this type of cancer. Cancer 2010;116:4914-25. (C) 2010 American Cancer Society
引用
收藏
页码:4914 / 4925
页数:12
相关论文
共 50 条
  • [31] Advances in Quality of Life Research Among Head and Neck Cancer Patients
    Sherman, Allen C.
    Simonton, Stephanie
    CURRENT ONCOLOGY REPORTS, 2010, 12 (03) : 208 - 215
  • [32] Advances in radiotherapy of head and neck cancers
    Tao, Yungan
    Daly-Schveitzer, Nicolas
    Lusinchi, Antoine
    Bourhis, Jean
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (03) : 194 - 199
  • [33] Photoacoustic Imaging as an Early Biomarker of Radio Therapeutic Efficacy in Head and Neck Cancer
    Rich, Laurie. J.
    Miller, Austin
    Singh, Anurag K.
    Seshadri, Mukund
    THERANOSTICS, 2018, 8 (08): : 2064 - 2078
  • [34] Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment
    Lucs, Alexandra V.
    Saltman, Benjamin
    Chung, Christine H.
    Steinberg, Bettie M.
    Schwartz, David L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (02): : 294 - 306
  • [35] DUSP2 methylation is a candidate biomarker of outcome in head and neck cancer
    Lo Nigro, Cristiana
    Vivenza, Daniela
    Denaro, Nerina
    Lattanzio, Laura
    Fortunato, Mirella
    Crook, Tim
    Merlan, Marco Carlo
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (13)
  • [36] Lessons and Opportunities for Biomarker-Driven Radiation Personalization in Head and Neck Cancer
    Rahimy, Elham
    Gensheimer, Michael F.
    Beadle, Beth
    Le, Quynh-Thu
    SEMINARS IN RADIATION ONCOLOGY, 2023, 33 (03) : 336 - 347
  • [37] YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer
    Jerhammar, Fredrik
    Johansson, Ann-Charlotte
    Ceder, Rebecca
    Welander, Jenny
    Jansson, Agneta
    Grafstrom, Roland C.
    Soderkvist, Peter
    Roberg, Karin
    ORAL ONCOLOGY, 2014, 50 (09) : 832 - 839
  • [38] Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
    Abu Eid, Rasha
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [39] Advances in Adoptive Cell Therapy for Head and Neck Cancer
    Norberg, Scott M.
    Hinrichs, Christian S.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2021, 54 (04) : 761 - 768
  • [40] Chemotherapy advances in locally advanced head and neck cancer
    Georges, Peter
    Rajagopalan, Kumar
    Leon, Chady
    Singh, Priya
    Ahmad, Nadir
    Nader, Kamyar
    Kubicek, Gregory J.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (05): : 966 - 972